Fluidigm Corporation Prices Initial Public Offering of Common Stock
February 9, 2011
SOUTH SAN FRANCISCO, Calif. - Fluidigm Corporation today announced the pricing of its initial public offering of 5,558,333 shares of its common stock at a price to the public of $13.50 per share. The shares of common stock have been approved to trade on The NASDAQ Global Market under the symbol “FLDM.” Deutsche Bank Securities [...]
Oxford Gene Technology Ltd. Expands Cytosure(TM) aCGH Product Range
February 9, 2011
Oxford, UK - Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has expanded its CytoSure™ product range to include high-throughput genomic DNA labelling kits and sample tracking spike-ins. These new products will further streamline workflow and minimise sample tracking errors when performing array comparative genomic hybridisation (aCGH). [...]
February 9, 2011
Boston, MA - The University of California Los Angeles (UCLA) School of Public Health and Los Alamos National Laboratory (LANL), as part of their development of the High Throughput Laboratory Network (HTLN) for infectious disease surveillance, have selected HighRes Biosolutions to automate a high-throughput extraction and screening system for their prototype laboratory, the Global Bio [...]
Gilson Opens New UK Operation for Pipettes, Automation and HPLC Products
February 9, 2011
LONDON - For over 30 years UK customers have trusted Gilson to provide them with products renowned for reliability, durability and greater precision. Thousands of UK bench scientists choose Gilson's range of PIPETMAN® and MICROMAN® pipettes and tips. Many will also use automated liquid handling and HPLC products. Gilson will provide you with full sales, [...]
February 9, 2011
London, UK, and Franklin Lakes, NJ - UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment. “This [...]
February 9, 2011
FREDERICK, Md. - Akonni Biosystems, a molecular diagnostics (MDx) company that develops rapid, low-cost and highly scalable solutions for infectious disease testing, today announced it has signed a license agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The license agreement provides Akonni full access, under patents owned or licensed by USAMRIID [...]
Salk Institute Celebrates Grand Opening of the Waitt Advanced Biophotonics Center
February 9, 2011
LA JOLLA, CA - The Waitt Advanced Biophotonics Center at the Salk Institute for Biological Studies officially opens on February 9, 2011 after quietly hiring two faculty members specializing in biophotonics—the science of using and manipulating light to investigate biological function—and building up its core facility's imaging capacity to rival most if not all academic [...]
The University of Nottingham Selects JPK’s Innovative ForceRobot System
February 9, 2011
Berlin - JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, is pleased to report on the first work from the University of Nottingham who have chosen the ForceRobot® 300 system for their School of Pharmacy. The Laboratory of Biophysics and Surface Analysis (LBSA), a multidisciplinary research division [...]
Phenomenex Announces that University of Delaware Drops Patent Lawsuit
February 9, 2011
TORRANCE, Calif. - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announced today that the University of Delaware has withdrawn a lawsuit for patent infringement brought against the company. The lawsuit, first filed in 2005, claimed that Phenomenex used technology from a University-owned patent related to [...]
February 8, 2011
CHICAGO - Baird Venture Partners (BVP), the U.S.-based venture capital fund of Baird Private Equity, announced today that its portfolio company Accuri Cytometers (Accuri) has signed a definitive agreement to be acquired by Becton, Dickinson and Company (BD) (NYSE: BDX), a leading global medical technology company. The acquisition is subject to regulatory approvals and is [...]